Asterand and 5AM Solutions Enter a Preferred Partnership Agreement
March 29 2011 - 9:00AM
Business Wire
Asterand plc (LSE:ATD), a leading provider of human tissue-based
services to pharmaceutical and biotechnology companies engaged in
drug discovery research, and 5AM Solutions, a life science
technology firm, today announce that they have entered into an
agreement to develop next generation virtual biobanking software
for exclusive use by Asterand and its collaborators. The aim of the
project is to enable broad access to geographically distinct
biospecimen resources in an easy to use manner, thereby
accelerating discovery in human disease research.
The companies will share development costs to build software
providing a standardized solution for the identification,
annotation and distribution of human biological materials for use
in research. Asterand and 5AM will electronically link disparate
biobanks to Asterand’s centralized biobanking operations in
Detroit, MI. The proprietary software will enable Asterand to
garner biospecimen and data requirements from researchers and query
partner biobanks for appropriate specimens. Once identified,
specimens will be selected and qualified for distribution by
Asterand.
“We are delighted to enter this partnership with 5AM,” noted Dr.
Victoria Blanc, Asterand’s Vice President of Strategic Planning and
Government Affairs. “Our customers require large numbers of highly
annotated biological specimens. We believe that this software will
assist us to meet this demand by allowing us to have vision into an
ever-increasing network of sophisticated biobanks. 5AM Solutions
has a proven track record of delivering scientifically driven
software solutions to meet the needs of researchers across
sectors.”
“We are thrilled to be working with Asterand on this novel
endeavor,” Brent Gendleman, Chief Executive Officer at 5AM
Solutions added. “Asterand has a global reach and a critical
mission to expand access to high quality human tissue. They are the
perfect partner to assist us in our goal to revolutionize the way
scientists acquire biospecimens and data needed to decrease the
timeline for meaningful results. Together we will create the
platform required to link distant biorepositories into a virtual
bank and enable controlled access to specimens for research.”
About ASTERAND
Asterand plc is a leading supplier of high quality human tissue
and tissue-based services. Our comprehensive approach to human
tissue and research services offers pharmaceutical, biotech and
diagnostic companies the unique opportunity to have one company
meet all of their human biomaterial needs along the continuum of
drug discovery and development. Our mission is to accelerate target
discovery and compound validation and enable pharmaceutical and
biotechnology companies to take safer and more effective drugs into
the market.
For more information, go to www.Asterand.com.
About 5AM Solutions
5AM Solutions develops innovative software solutions for life
science professionals. The company helps evolve the way biomedical
researchers work and collaborate by using software to reveal new
insights hidden in vast amounts of data, facilitate translational
research, and solve workflow challenges. The company’s solutions
overcome IT-based roadblocks to discovery and accelerate progress
toward the ultimate goal of better health and improved patient
outcomes.
For more information, go to www.5amsolutions.com.
Bioseek (LSE:ATD)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioseek (LSE:ATD)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bioseek (London Stock Exchange): 0 recent articles
More Asterand plc News Articles